15 April 2022

Safety Alerts

Reference: CIR-2022-00000088

To all Health facilities / all health care practitioners in Dubai's private health sector

Referring to the above subject, DHA notifies all health facilities regarding the circular issued by the MOHAP for perusal and adhere to what is stated

 

Recall & Suspension of registration for Pharmaceutical Product Rabezole 20mg E.C. Tablets

Lifting the Suspension on the Registration & Marketing of the Pharmaceutical Products Dialon XR 500mg, 750mg & 1000mg Tablets

URGENT FIELD SAFETY NOTICE Dragonfly OpStar™ Imaging Catheter

Ministerial Decree No. 253 for the year 2020 regarding prescribing and dispensing controlled medications

 

Thanks in advance for your good co-operation

Drug Control Section

Health Regulation Sector

DHA

 

 

Supporting Documents:

سحب وتعليق تسجيل المنتج الطبي - Rabezole 20mg-1.pdf:

View Document

رفع التعليق عن تسجيل وتسويق المستحضرات الصيدلانية - Dialon XR - Julphar-1.pdf:

View Document

Dragonfly OpStar Imaging Catheter 1.pdf:

View Document

ق و 253 لسنة 2020 ضوابط وقواعد وصف وصرف بعض الأدوية المراقبة 1.pdf:

View Document